Oct
11
2020
FDA Advisory Board In Favor of ALKS 3831 for Schizophrenia & Bipolar Disorder – MD Magazine
FDA Advisory Board In Favor of ALKS 3831 for Schizophrenia & Bipolar Disorder MD Magazine Alkermes’ schizophrenia drug succeeds in FDA adcomm vote Boston Business Journal FDA Advisory Committee Votes in Support...